AUAnna A. Uspenskaya

Anna A. Uspenskaya

*This is an algorithmically generated author record based on publicly available information.

Anna A. Uspenskaya has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Papillary thyroid carcinoma with angioinvasion: a literature review

    by A. V. Zolotoukho, A. A. Uspenskaya, R. A. Chernikov, I. V. Sleptsov, V. P. Govorushkina, I. M. Feldsherov

    Papillary thyroid carcinoma (PTC) is the most common form of differentiated thyroid cancer and it is generally characterized by an indolent course. The role of the ability to invade blood vessels and its impact on the prognosis in PTC remain uncertain. The authors conducted an electronic search of publications within the PubMed database. A number of studies demonstrate angioinvasion ceasing to be an independent factor of poor prognosis upon multivariate analysis. The existence of conflicting data on the prognostic role of angioinvasion in PTC may be explained by the difficulty in differentiating between blood vessel and lymphatic vessel invasion, as well as by the use of different criteria for true angioinvasion during morphological examination of surgical specimens. Literature data on the prognostic role of the extent of blood vessel invasion in PTC are limited to a few studies and do not allow for conclusions to be drawn regarding any threshold value for risk of recurrence stratification. When examining tumors of larger size, the dependence of the number of detected invasion foci on the number of examined tumor sections becomes particularly relevant. The issue of the prognostic value of angioinvasion as a risk factor for recurrence and progression of PTC, and as a possible basis for choosing more aggressive treatment tactics, requires further investigation.

  • Open Access

    Could SLC26A7 Be a Promising Marker for Preoperative Diagnosis of High-Grade Papillary Thyroid Carcinoma?

    by Sergei E. Titov, Evgeniya S. Kozorezova, Sergei A. Lukyanov, Sergei V. Sergiyko, Pavel S. Demenkov, Yulia A. Veryaskina, Sergey L. Vorobyev, Ilya V. Sleptsov, Roman A. Chernikov, Natalia I. Timofeeva, et al.

    Background/Objectives: A modern classification distinguishes between two nosological entities posing an intermediate risk between differentiated and anaplastic carcinoma: poorly differentiated thyroid carcinoma and differentiated high-grade thyroid carcinoma. There are currently few studies searching for the preoperative molecular genetic markers of high-grade papillary thyroid carcinoma (PTC HG), primarily because of a recent WHO reclassification and singling out of a separate entity: high-grade follicular cell-derived nonanaplastic thyroid carcinoma. Therefore, this work was aimed at identifying PTC HG-specific microRNAs and mRNAs that reliably distinguish them from differentiated papillary thyroid carcinoma in preoperative cytology specimens (fine-needle aspiration biopsies). Methods: A molecular genetic profile (expression levels of 14 genes and eight microRNAs) was studied in 110 cytology specimens from patients with PTC: 13 PTCs HG and 97 PTCs without features of HG. Results: Of the examined eight microRNAs and 14 genes, significant differences in the expression levels between the PTC and PTC HG groups were revealed for genes SLC26A7, TFF3, and TPO. Only one gene (SLC26A7) proved to be crucial for detecting PTC HG. It showed the largest area under the ROC curve (0.816) in differentiation between the PTC and PTC HG groups and was the key element of the decision tree by ensuring 54% sensitivity and 87.6% specificity. Conclusions: Early preoperative diagnosis of PTC HG in patients with early stages of this cancer type will allow clinicians to modify a treatment strategy toward a larger surgery volume and lymph node dissection and may provide indications for subsequent radioactive iodine therapy.


  • Persistence of primary hyperparathyroidism: a single-center experience

    by Dmitrii M. Buzanakov, Ilya V. Sleptsov, Arseny A. Semenov, Roman A. Chernikov, Konstantin Y. Novokshonov, Yulia V. Karelina, Natalya I. Timofeeva, Anna A. Uspenskaya, Viktor A. Makarin, Igor K. Chinchuk, et al.

    Background Parathyroidectomy is the only definitive treatment for primary hyperparathyroidism (PHPT). Precise localization of abnormal glands is a key to a successful surgery. Most patients are expected to be successfully treated with focused parathyroidectomy. However, this approach is associated with a risk of existing multiglandular disease which may lead to the postoperative persistence of PHPT. Methods Eight hundred ten patients who underwent an initial surgery for PHPT at SPBU Hospital in 2017–2018 were included in the study. Preoperative imaging results were evaluated. Multivariate logistic regressions were calculated to estimate predictive values of preoperative data for the risk of postoperative persistence and risk of MGD. Results Multiglandular disease was found to be a leading cause of persistent hyperparathyroidism. An anamnesis of thyroid surgery was found to be a significant risk factor for the persistence of hyperparathyroidism. The rate of persistence did not differ significantly between groups with bilateral neck exploration and focused parathyroidectomy. Age, sex, body mass index as well as negative results of preoperative US, MIBI, and 4D CT were not independently associated with a higher risk of MGD. All preoperative imaging modalities showed from low to moderate sensitivity for the detection of MGD. The frequency of cases of a missed second adenoma did not differ significantly between patients with concordant and discordant preoperative data. There were 7 cases with previously unsuspected second adenomas found solely due to bilateral neck exploration. Conclusions None of the combination of preoperative visualization modalities was able to rule out the MGD and reliably identify patients for focused parathyroidectomy. Additional preoperative visualization failed to improve overall results. Bilateral neck exploration appeared to have a slight benefit for the patients with concordant preoperative imaging results.


  • Open Access

    INTRAOPERATIVE CONTINUOUS NEUROMONITORING OF LARYNGEAL RECCURENT NERVES IN PATIENTS WITH THYROID CANCER

    by Виктор Макарьин, Anna Uspenskaya, Arseniy Semenov, Natalya Timofeeva, Roman Chernikov, Ilya Sleptsov, Igor Chinchuk, Yuliya Karelina, Konstantin Novokshonov, Yelisey Fedorov, et al.

    Laryngeal muscles paresis ranks second in prevalence of postoperative complications after thyroid surgery. Intraoperative neuromonitoring (IONM) of recurrent laryngeal nerve (RLN) results in reduction of cases with dysphonia and prevents such severe complication as bilateral paresis. Currently there are two types of monitoring: intermittent and continual. When using intermittent IONM surgeon has no opportunity to control electrophysiology state of RLN during intervals between stimulations. In case of continual IONM date on amplitude and latency are available to surgeon in real time every second, allowing him instantly react to any disturbance of neural transmission to prevent its damage by changing surgical manipulation. This work presents the first experience of using continual neuromonitoring of RLN in Russia, the procedure is described in details its safety. It is represented the possibility of prevention of bilateral laryngeal muscles paresis. Парез мышц гортани является вторым после гипопаратиреоза по распространенности осложнением при хирургических вмешательствах на щитовидной железе. Использование интраоперационного нейромониторинга помогает сократить количество нарушений голоса и предотвратить такое грозное осложнение, как двусторонний парез мышц гортани. В настоящее время существует два вида мониторинга: переменный и постоянный. При переменном нейромониторинге у оператора нет возможности контролировать электрофи-зиологическое состояние гортанных нервов в промежутке между стимуляциями. При постоянном мониторинге данные по амплитуде и латентности доступны хирургу в реальном времени ежесекундно, что позволяет моментально отреагировать на нарушения проведения нервного импульса по нерву и предотвратить его повреждение, изменив хирургическую тактику. В работе представлен первый опыт выполнения постоянного мониторинга в России, подробно описана методика, показана безопасность, продемонстрирована возможность профилактики двустороннего пареза мышц гортани у пациентов с раком щитовидной железы. Цель: оценить результаты использования постоянного мониторинга гортанных нервов при хирургических вмешательствах на щитовидной железе и влияние его на сердечно-сосудистую систему пациента в процессе выполнения оперативного вмешательства. Материалы и методы: с октября 2016 по август 2017 гг. на базе отделения эндокринной хирургии Клиники высоких медицинских технологий им. Н. И. Пирогова Санкт-Петербургского университета (Северо-Западный центр эндокринологии и эндокринной хирургии) 118 пациентам были выполнены оперативные вмешательства на щитовидной железе с установкой дельта-электрода на n. vagus с постоянной стимуляцией последнего. Группа пациентов включала: 101 пациента с диагнозом «папиллярная карцинома», 12 пациентов с диагнозом «медуллярная карцинома», 5 пациентов с диагнозом «анапластическая карцинома». Для проведения нейромониторинга использовали нейромонитор С2 (Inomed, Emmendingen, Germany). Всем пациентам перед операцией и в послеоперационном периоде выполняли ларингоскопию и регистрировали изменения функции голосовых складок. В работе проведен анализ взаимосвязи изменения амплитуды и латентности при проведении нейромониторинга и развития послеоперационного пареза мышц гортани, определены средние значения по амплитуде и латентности для блуждающего нерва слева и справа. Результаты. В исследуемой группе было следующее распределение пациентов по полу: 94 женщины и 24 мужчины. Средний возраст женщин и мужчин составил 46,1 ± 18 и 44,2 ± 15 лет соответственно. Получено достоверно значимое снижение уровня амплитуды в V2 в сравнении с V1 (p=0,0454), при этом в R2 значимых изменений в сравнении с R1 не получено (p=0,8927). В отведениях V2 в сравнении с V1...